Cited by 33Neurological Disorders and TreatmentsAcute Ischemic Stroke ManagementMedicinal Plants and Neuroprotection

Neuroprotective effect of asiatic acid in rat model of focal embolic stroke

Open access
Lee, Ki Yong, Bae, Ok-Nam, Weinstock, Shelley, Kassab, Mounzer, Majid, Arshad·2014·Biological and Pharmaceutical Bulletin

Abstract

Asiatic acid (AA) is a pleiotropic neuroprotective agent that has been shown to attenuate infarct volume in mouse and rat models of focal ischemia and has a long clinically relevant therapeutic time-window. Because in a future trial AA would be administered with tissue-plasminogen activator (t-PA), the only approved acute stroke therapy, we sought to determine the effect of AA when co-administered with t-PA in a rat focal embolic stroke model. Male rats were treated with AA (75 mg/kg) alone, low-dose t-PA (2.5 mg/kg) alone, or a combination of AA and low-dose t-PA at 3 h after inducing embolic stroke. AA significantly reduced infarct volume whereas low-dose t-PA alone did not reduce infarct volume compared with vehicle. Significantly, combination treatment further enhanced reduction of infarct volume versus AA alone. Treatment with AA reduced cytochrome c (CytoC) and apoptosis-inducing factor (AIF) release from brain mitochondria after ischemia. AA was also neuroprotective against L-glutamate-induced toxicity in primary cortical neurons. In summary, combination treatment with AA and low-dose t-PA at 3 h after embolic stroke reduces infarct volume, improves neurological outcome, and provides neuroprotection. The neuroprotective effects of AA were partially associated with reduction of AIF and CytoC release.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1248/bpb.b14-00055

Cites

25 of 27 references verified0 citation errors · 2 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In vitro studies show CAW whole extract and isolated compounds facilitate neurite outgrowth and elicit neuroprotection.

    “Previously, in vitro studies have shown that both CAW whole extract and isolated compounds (detailed in a review [32]) facilitate neurite outgrowth [6,28,106], and elicit neuroprotection [107,108,109,110,111].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 4

  1. Mook-Jung I, Shin JE, Yun SH, Huh K, Koh JY, Park HK, Jew SS, Jung MW. Protective effects of asiaticoside derivatives against beta- amyloid neurotoxicity. J. Neurosci. Res., 58, 417-425 (1999). · DOI
  2. Zhang L, Zhang ZG, Zhang RL, Lu M, Adams J, Elliott PJ, Chopp M. Postischemic (6-h) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia. Stroke, 32, 2926-2931 (2001). · DOI
  3. Brown MR, Sullivan PG, Geddes JW. Synaptic mitochondria are more susceptible to Ca 2+ overload than nonsynaptic mitochondria. J. Biol. Chem., 281, 11658-11668 (2006). · DOI
  4. Clark RS, Nathaniel PD, Zhang X, Dixon CE, Alber SM, Watkins SC, Melick JA, Kochanek PM, Graham SH. boc-Aspartyl (OMe)- fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats. J. Cereb. Blood Flow Metab., 27, 316-326 (2007). · DOI

Cited by

Sorted by citations

Authors
Lee, K. Y., Bae, O.-N., Weinstock, S., Kassab, M., & Majid, A.
Affiliations
  • Korea University (KR)
  • Hanyang University (KR)
  • ZYMES, LLC
  • Michigan State University (US)
Venue
Biological and Pharmaceutical Bulletin
Published
2014
Volume
37
Issue
8
Pages
1397-1401
ISSN
  • 0918-6158 (ISSN-L)
  • 1347-5215
OpenAlex
W2085392936
Cited by
31
References
25
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 1
FWCI
1.56
Type
journal article
Language
en
Open access
Locations
  • Biological and Pharmaceutical Bulletin (publishedVersion)
  • PubMed (publishedVersion)
  • The Royal Society of Chemistry’s Journals, Books and Databases (The Royal Society of Chemistry) (submittedVersion)
Funders
  • National Research Foundation
  • National Research Foundation of Korea
  • National Institutes of Health
Topics
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords
asiatic acid, neuroprotection, embolic stroke, focal cerebral ischemia, tissue plasminogen activator, combination therapy, infarct size, apoptosis-inducing factor, cytochrome c release, mitochondrial apoptosis, cortical neurons, neurological outcome
MeSH terms
Animals, Disease Models, Animal, Male, Mitochondria, Neurons, Rats, Sprague-Dawley, Rats, Wistar, Neuroprotective Agents, Infarction, Middle Cerebral Artery, Cytochromes c, Apoptosis Inducing Factor, Pentacyclic Triterpenes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review